Compounds > naringenin

naringenin and Atherosclerosis

naringenin has been researched along with Atherosclerosis in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (7.69)	29.6817
2010's	9 (69.23)	24.3611
2020's	3 (23.08)	2.80

Authors

Authors	Studies
Hua, Y; Ling, S; Wang, J; Wu, R; Xu, X	1
Fan, G; He, F; Hua, Y; Li, X; Yang, Z; Zhang, L	1
Jin, T; Li, H; Li, Y; Xiao, H; Xu, F; Zhang, Y; Zhang, Z; Zhao, R	1
Alba, G; Geniz, I; Jiménez, J; Reyes-Quiroz, ME; Saenz, J; Santa-María, C; Sobrino, F	1
Burke, AC; Edwards, JY; Huff, MW; Morrow, MR; Sawyez, CG; Sutherland, BG; Telford, DE	1
Brighenti, F; Calani, L; Curella, V; Dall'Asta, M; Del Rio, D; Derlindati, E; Mena, P; Ray, S; Zavaroni, I	1
Daglia, M; Mansouri, K; Nabavi, SF; Nabavi, SM; Orhan, IE; Tenore, GC	1
Kim, DI; Kim, WJ; Lee, EJ; Moon, SK	1
Assini, JM; DiMattia, AS; Huff, MW; Khami, M; Koppes, JB; Mulvihill, EE; Sawyez, CG; Sutherland, BG; Whitman, SC	1
Kim, IS; Kim, Y; Kim, YH; Lee, JJ; Myung, CS; Nhiem, NX; Yi, H	1
Assini, JM; Huff, MW; Mulvihill, EE	1
Assini, JM; Chhoker, S; Edwards, JY; Felder, SL; Gros, R; Huff, MW; Mulvihill, EE; Sawyez, CG; Sutherland, BG; Telford, DE	1
Bennetau-Pelissero, C; Bérard, AM; Chanet, A; Claude, S; Kamran Khan, M; Maier, JA; Mazur, A; Milenkovic, D; Morand, C; Rakotomanomana, N; Shinkaruk, S	1

Reviews

2 review(s) available for naringenin and Atherosclerosis

Article	Year
Naringenin and atherosclerosis: a review of literature. Current pharmaceutical biotechnology, 2015, Volume: 16, Issue:3 Topics: Animals; Antioxidants; Atherosclerosis; Flavanones; Flavonoids; Humans; Macrophages; Oxidative Stress	2015
Citrus flavonoids and lipid metabolism. Current opinion in lipidology, 2013, Volume: 24, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Citrus; Dyslipidemias; Flavanones; Flavones; Hesperidin; Humans; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Oxidation-Reduction; Phytotherapy	2013

Other Studies

11 other study(ies) available for naringenin and Atherosclerosis

Article	Year
Naringenin ameliorates vascular senescence and atherosclerosis involving SIRT1 activation. The Journal of pharmacy and pharmacology, 2023, Aug-01, Volume: 75, Issue:8 Topics: Animals; Apolipoproteins E; Atherosclerosis; Cellular Senescence; Endothelial Cells; Hydrogen Peroxide; Mice; Mice, Knockout, ApoE; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sirtuin 1	2023
Anti-atherosclerotic effects of naringenin and quercetin from Folium Artemisiae argyi by attenuating Interleukin-1 beta (IL-1β)/ matrix metalloproteinase 9 (MMP9): network pharmacology-based analysis and validation. BMC complementary medicine and therapies, 2023, Oct-25, Volume: 23, Issue:1 Topics: Atherosclerosis; Drugs, Chinese Herbal; Humans; Interleukin-1beta; Interleukin-6; Matrix Metalloproteinase 9; Molecular Docking Simulation; Network Pharmacology; Quercetin; Vascular Endothelial Growth Factor A	2023
Naringenin promotes cell autophagy to improve high-fat-diet-induced atherosclerosis in ApoE-/- mice. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2021, Volume: 54, Issue:4 Topics: Animals; Apolipoproteins E; Atherosclerosis; Autophagy; Flavanones; Mice	2021
Grapefruit Flavonoid Naringenin Regulates the Expression of LXRα in THP-1 Macrophages by Modulating AMP-Activated Protein Kinase. Molecular pharmaceutics, 2018, 05-07, Volume: 15, Issue:5 Topics: AMP-Activated Protein Kinases; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Biological Transport; Cell Line; Cell Movement; Cholesterol; Citrus paradisi; Flavanones; Flavonoids; Foam Cells; Gene Expression Regulation; Humans; Liver X Receptors; Macrophages; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Up-Regulation	2018
Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr Atherosclerosis, 2019, Volume: 286 Topics: Animals; Atherosclerosis; Diet, High-Fat; Flavanones; Male; Mice; Remission Induction	2019
Effects of naringenin and its phase II metabolites on in vitro human macrophage gene expression. International journal of food sciences and nutrition, 2013, Volume: 64, Issue:7 Topics: Anti-Inflammatory Agents; Atherosclerosis; Cell Culture Techniques; Citrus; Diet; Flavanones; Gene Expression; Humans; Macrophages; Metabolic Detoxication, Phase II; Plant Extracts	2013
Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells. Molecular nutrition & food research, 2009, Volume: 53, Issue:12 Topics: Animals; Apoptosis; Atherosclerosis; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Flavanones; Interleukins; Intracellular Signaling Peptides and Proteins; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Phosphorylation; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Tumor Necrosis Factor-alpha	2009
Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:4 Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cholesterol; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Fatty Liver; Flavanones; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptors, LDL; Time Factors; Triglycerides	2010
(2S)-naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest. Journal of ethnopharmacology, 2012, Feb-15, Volume: 139, Issue:3 Topics: Atherosclerosis; Cell Cycle Checkpoints; Cell Line; Cell Proliferation; Cyclin-Dependent Kinases; Cyclins; DNA; Dose-Response Relationship, Drug; Flavanones; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phytotherapy; Plant Extracts; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Typhaceae	2012
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice. Journal of lipid research, 2013, Volume: 54, Issue:3 Topics: Animals; Atherosclerosis; Cholesterol; Fatty Liver; Flavanones; Flavonoids; Inflammation; Insulin Resistance; Male; Mice; Mice, Knockout; Receptors, LDL	2013
Flavanone metabolites decrease monocyte adhesion to TNF-α-activated endothelial cells by modulating expression of atherosclerosis-related genes. The British journal of nutrition, 2013, Volume: 110, Issue:4 Topics: Atherosclerosis; Cell Adhesion; Endothelial Cells; Flavanones; Gene Expression Profiling; Gene Expression Regulation; Glucuronides; Hesperidin; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Monocytes; Sulfates; Tumor Necrosis Factor-alpha	2013